CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results

- Presented key product lines spanning aesthetic, wound care, bone and spine, and surgical fields - Signed supply agreements totaling KRW 5.3 billion with partners from Singapore, Malaysia, Pakistan, Taiwan, and the Philippines SEOUL, South Korea, April 6, 2026 /PRNewswire/ -- CGBIO (CEO...